Actively Recruiting
Blood Pressure Effects on Cognition and Brain Blood Flow in PD
Led by University of California, San Diego · Updated on 2026-04-27
60
Participants Needed
1
Research Sites
243 weeks
Total Duration
On this page
Sponsors
U
University of California, San Diego
Lead Sponsor
B
Beth Israel Deaconess Medical Center
Collaborating Sponsor
AI-Summary
What this Trial Is About
Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide. Besides causing symptoms that impair movement, PD also causes non-motor symptoms, such as problems thinking and orthostatic hypotension (OH), i.e., low blood pressure (BP) when standing. About one-third of people with PD have OH, which can cause sudden, temporary symptoms while upright, including lightheadedness, dizziness, and fainting. People with PD and OH can also experience problems thinking that happen only while upright and not while sitting - this can occur without other symptoms, such as feeling dizzy or faint. However, the level of low BP that can affect thinking remains unknown, and no guidelines exist for treating OH when it happens without symptoms. This is significant because OH could be a treatable risk factor for thinking problems in PD, but OH is often not treated if people do not report obvious symptoms. This project's goal is to determine how BP affects brain function in PD. The proposed experiments will measure BP and brain blood flow continuously in real-time using innovative wearable technology. Persons with PD with OH and without OH will undergo repeated cognitive tests while supine (lying down) and while upright. I will study the associations between BP, thinking abilities, and brain blood flow, and will compare groups with and without OH. These findings could be important because if a certain level of BP correlates with thinking abilities, then treating OH in PD may prevent thinking problems, which would improve health-related quality of life and reduce disability and healthcare costs.
CONDITIONS
Official Title
Blood Pressure Effects on Cognition and Brain Blood Flow in PD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of idiopathic Parkinson Disease using Movement Disorders Society Clinical Diagnostic Criteria
- Age at least 50 years old
- Hoehn & Yahr stages I-III indicating early to moderate PD and ability to walk without assistance
- Proficiency in English at native speaker level
You will not qualify if you...
- Involuntary movements (tremor or dyskinesia) greater than 3 cm in amplitude unless controlled by medication
- Diagnosis of dementia including Parkinson Disease dementia
- History of deep brain stimulation surgery
- Current unstable or active medical problems like heart failure, liver failure, or pneumonia
- Moderate or severe carotid artery stenosis
- History of cerebral infarction or hemorrhage
- Uncontrolled diabetes or other systemic diseases causing autonomic failure
- Fainting episodes within the past week
- Illiteracy or inability to read
- Taking antihypertensive medications, diuretics, or alpha-adrenergic blocking medications
- Uncorrected hearing or vision impairments
- Currently pregnant (confirmed by urine pregnancy test if applicable)
- Any other condition that could increase risk as determined by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California San Diego
San Diego, California, United States, 92093
Actively Recruiting
Research Team
K
Katherine Longardner, MD
CONTACT
M
Michael Skipworth, BS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here